Market Research Report

Vitamin K Antagonists (VKA) Market - Global Outlook and Forecast 2022-2028

  • AMR ID : MMG-2359782
  • CAT ID : 7
  • Pages : 116
  • Date : Mar 2022
 

Vitamin K is a kind of substance with biological activity of leaf green quinone.
This report contains market size and forecasts of Vitamin K Antagonists (VKA) in global, including the following market information:
Global Vitamin K Antagonists (VKA) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Vitamin K Antagonists (VKA) Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Vitamin K Antagonists (VKA) companies in 2021 (%)
The global Vitamin K Antagonists (VKA) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Vitamin K Antagonists Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vitamin K Antagonists (VKA) include Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo and Otsuka, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vitamin K Antagonists (VKA) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vitamin K Antagonists (VKA) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Vitamin K Antagonists (VKA) Market Segment Percentages, by Type, 2021 (%)
Oral Vitamin K Antagonists
Injection Vitamin K Antagonists
Global Vitamin K Antagonists (VKA) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Vitamin K Antagonists (VKA) Market Segment Percentages, by Application, 2021 (%)
VTE
ACS/MI
AF
Others
Global Vitamin K Antagonists (VKA) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Vitamin K Antagonists (VKA) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vitamin K Antagonists (VKA) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Vitamin K Antagonists (VKA) revenues share in global market, 2021 (%)
Key companies Vitamin K Antagonists (VKA) sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Vitamin K Antagonists (VKA) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
Pfizer
Aspen
The Medicines Company

1 Introduction to Research & Analysis Reports
1.1 Vitamin K Antagonists (VKA) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vitamin K Antagonists (VKA) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vitamin K Antagonists (VKA) Overall Market Size
2.1 Global Vitamin K Antagonists (VKA) Market Size: 2021 VS 2028
2.2 Global Vitamin K Antagonists (VKA) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Vitamin K Antagonists (VKA) Sales: 2017-2028
3 Company Landscape
3.1 Top Vitamin K Antagonists (VKA) Players in Global Market
3.2 Top Global Vitamin K Antagonists (VKA) Companies Ranked by Revenue
3.3 Global Vitamin K Antagonists (VKA) Revenue by Companies
3.4 Global Vitamin K Antagonists (VKA) Sales by Companies
3.5 Global Vitamin K Antagonists (VKA) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Vitamin K Antagonists (VKA) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Vitamin K Antagonists (VKA) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vitamin K Antagonists (VKA) Players in Global Market
3.8.1 List of Global Tier 1 Vitamin K Antagonists (VKA) Companies
3.8.2 List of Global Tier 2 and Tier 3 Vitamin K Antagonists (VKA) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Vitamin K Antagonists (VKA) Market Size Markets, 2021 & 2028
4.1.2 Oral Vitamin K Antagonists
4.1.3 Injection Vitamin K Antagonists
4.2 By Type - Global Vitamin K Antagonists (VKA) Revenue & Forecasts
4.2.1 By Type - Global Vitamin K Antagonists (VKA) Revenue, 2017-2022
4.2.2 By Type - Global Vitamin K Antagonists (VKA) Revenue, 2023-2028
4.2.3 By Type - Global Vitamin K Antagonists (VKA) Revenue Market Share, 2017-2028
4.3 By Type - Global Vitamin K Antagonists (VKA) Sales & Forecasts
4.3.1 By Type - Global Vitamin K Antagonists (VKA) Sales, 2017-2022
4.3.2 By Type - Global Vitamin K Antagonists (VKA) Sales, 2023-2028
4.3.3 By Type - Global Vitamin K Antagonists (VKA) Sales Market Share, 2017-2028
4.4 By Type - Global Vitamin K Antagonists (VKA) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Vitamin K Antagonists (VKA) Market Size, 2021 & 2028
5.1.2 VTE
5.1.3 ACS/MI
5.1.4 AF
5.1.5 Others
5.2 By Application - Global Vitamin K Antagonists (VKA) Revenue & Forecasts
5.2.1 By Application - Global Vitamin K Antagonists (VKA) Revenue, 2017-2022
5.2.2 By Application - Global Vitamin K Antagonists (VKA) Revenue, 2023-2028
5.2.3 By Application - Global Vitamin K Antagonists (VKA) Revenue Market Share, 2017-2028
5.3 By Application - Global Vitamin K Antagonists (VKA) Sales & Forecasts
5.3.1 By Application - Global Vitamin K Antagonists (VKA) Sales, 2017-2022
5.3.2 By Application - Global Vitamin K Antagonists (VKA) Sales, 2023-2028
5.3.3 By Application - Global Vitamin K Antagonists (VKA) Sales Market Share, 2017-2028
5.4 By Application - Global Vitamin K Antagonists (VKA) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Vitamin K Antagonists (VKA) Market Size, 2021 & 2028
6.2 By Region - Global Vitamin K Antagonists (VKA) Revenue & Forecasts
6.2.1 By Region - Global Vitamin K Antagonists (VKA) Revenue, 2017-2022
6.2.2 By Region - Global Vitamin K Antagonists (VKA) Revenue, 2023-2028
6.2.3 By Region - Global Vitamin K Antagonists (VKA) Revenue Market Share, 2017-2028
6.3 By Region - Global Vitamin K Antagonists (VKA) Sales & Forecasts
6.3.1 By Region - Global Vitamin K Antagonists (VKA) Sales, 2017-2022
6.3.2 By Region - Global Vitamin K Antagonists (VKA) Sales, 2023-2028
6.3.3 By Region - Global Vitamin K Antagonists (VKA) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Vitamin K Antagonists (VKA) Revenue, 2017-2028
6.4.2 By Country - North America Vitamin K Antagonists (VKA) Sales, 2017-2028
6.4.3 US Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.4.4 Canada Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.4.5 Mexico Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Vitamin K Antagonists (VKA) Revenue, 2017-2028
6.5.2 By Country - Europe Vitamin K Antagonists (VKA) Sales, 2017-2028
6.5.3 Germany Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.5.4 France Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.5.5 U.K. Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.5.6 Italy Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.5.7 Russia Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.5.8 Nordic Countries Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.5.9 Benelux Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Vitamin K Antagonists (VKA) Revenue, 2017-2028
6.6.2 By Region - Asia Vitamin K Antagonists (VKA) Sales, 2017-2028
6.6.3 China Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.6.4 Japan Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.6.5 South Korea Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.6.6 Southeast Asia Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.6.7 India Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Vitamin K Antagonists (VKA) Revenue, 2017-2028
6.7.2 By Country - South America Vitamin K Antagonists (VKA) Sales, 2017-2028
6.7.3 Brazil Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.7.4 Argentina Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Vitamin K Antagonists (VKA) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Vitamin K Antagonists (VKA) Sales, 2017-2028
6.8.3 Turkey Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.8.4 Israel Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.8.5 Saudi Arabia Vitamin K Antagonists (VKA) Market Size, 2017-2028
6.8.6 UAE Vitamin K Antagonists (VKA) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Vitamin K Antagonists (VKA) Major Product Offerings
7.1.4 Sanofi Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Key News
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporate Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Major Product Offerings
7.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.2.5 Bristol-Myers Squibb Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Vitamin K Antagonists (VKA) Major Product Offerings
7.3.4 Bayer Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.3.5 Bayer Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Major Product Offerings
7.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Genentech (Roche)
7.5.1 Genentech (Roche) Corporate Summary
7.5.2 Genentech (Roche) Business Overview
7.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Major Product Offerings
7.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.5.5 Genentech (Roche) Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Major Product Offerings
7.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.6.5 Boehringer Ingelheim Key News
7.7 Lilly
7.7.1 Lilly Corporate Summary
7.7.2 Lilly Business Overview
7.7.3 Lilly Vitamin K Antagonists (VKA) Major Product Offerings
7.7.4 Lilly Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.7.5 Lilly Key News
7.8 Daiichi Sankyo
7.8.1 Daiichi Sankyo Corporate Summary
7.8.2 Daiichi Sankyo Business Overview
7.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Major Product Offerings
7.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.8.5 Daiichi Sankyo Key News
7.9 Otsuka
7.9.1 Otsuka Corporate Summary
7.9.2 Otsuka Business Overview
7.9.3 Otsuka Vitamin K Antagonists (VKA) Major Product Offerings
7.9.4 Otsuka Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.9.5 Otsuka Key News
7.10 AstraZeneca
7.10.1 AstraZeneca Corporate Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Vitamin K Antagonists (VKA) Major Product Offerings
7.10.4 AstraZeneca Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.10.5 AstraZeneca Key News
7.11 Pfizer
7.11.1 Pfizer Corporate Summary
7.11.2 Pfizer Vitamin K Antagonists (VKA) Business Overview
7.11.3 Pfizer Vitamin K Antagonists (VKA) Major Product Offerings
7.11.4 Pfizer Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.11.5 Pfizer Key News
7.12 Aspen
7.12.1 Aspen Corporate Summary
7.12.2 Aspen Vitamin K Antagonists (VKA) Business Overview
7.12.3 Aspen Vitamin K Antagonists (VKA) Major Product Offerings
7.12.4 Aspen Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.12.5 Aspen Key News
7.13 The Medicines Company
7.13.1 The Medicines Company Corporate Summary
7.13.2 The Medicines Company Vitamin K Antagonists (VKA) Business Overview
7.13.3 The Medicines Company Vitamin K Antagonists (VKA) Major Product Offerings
7.13.4 The Medicines Company Vitamin K Antagonists (VKA) Sales and Revenue in Global (2017-2022)
7.13.5 The Medicines Company Key News
8 Global Vitamin K Antagonists (VKA) Production Capacity, Analysis
8.1 Global Vitamin K Antagonists (VKA) Production Capacity, 2017-2028
8.2 Vitamin K Antagonists (VKA) Production Capacity of Key Manufacturers in Global Market
8.3 Global Vitamin K Antagonists (VKA) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vitamin K Antagonists (VKA) Supply Chain Analysis
10.1 Vitamin K Antagonists (VKA) Industry Value Chain
10.2 Vitamin K Antagonists (VKA) Upstream Market
10.3 Vitamin K Antagonists (VKA) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vitamin K Antagonists (VKA) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Request Sample Report

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, AMR offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe